GlassScriptPhysician profile
Jung-Woo Ma
NPI 1073771515
$2,729.95
in general payments reported to CMS, 2019-2025
33 companies · $485 in 2025
The $485 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,267 · 2020: $783 · 2021: $147 · 2022: $27.72 · 2024: $20.24 · 2025: $485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $254 · Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $253.93 |
| Food and Beverage | $251.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $485.11 | 2025 | Sprint Pns System |
| Boston Scientific Corporation | $308.50 | 2019-2024 | Avista Mri |
| Daiichi Sankyo INC. | $215.20 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $165.98 | 2019-2020 | |
| Tersera Therapeutics LLC | $148.01 | 2019 | |
| Davol INC. | $146.80 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $145.99 | 2019-2020 | |
| Nevro Corp. | $126.97 | 2020 | |
| Scilex Pharmaceuticals INC. | $111.81 | 2019-2020 | |
| Redhill Biopharma INC. | $92.13 | 2020 | |
| Sentynl Therapeutics, INC. | $87.48 | 2019 | |
| Collegium Pharmaceutical, INC. | $81.26 | 2019-2020 | |
| Abbott Laboratories | $78.45 | 2020 | |
| Biodelivery Sciences International, INC. | $62.01 | 2020 | |
| Allergan, INC. | $47.73 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $46.17 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $45.34 | 2019 | |
| Pfizer INC. | $38.56 | 2019 | |
| Bioventus LLC | $33.13 | 2019 | |
| Arbor Pharmaceuticals, INC. | $28.07 | 2019 | |
| Mallinckrodt Enterprises LLC | $27.20 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.29 | 2019 | |
| Pacira Therapeutics, INC. | $23.79 | 2019 | |
| Grt US Holding, INC. | $21.97 | 2020 | |
| Shionogi INC | $19.22 | 2019 | |
| Flowonix Medical Incorporated | $19.19 | 2020 | |
| Lilly USA, LLC | $15.98 | 2020 | |
| Si-Bone, INC. | $15.80 | 2019 | |
| Assertio Therapeutics, INC. | $14.79 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.58 | 2020 | |
| Amgen INC. | $13.28 | 2019 | |
| Tanabe Pharma America, INC. | $13.11 | 2019 | |
| Medtronic Vascular, INC. | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jung-Woo Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.